What is PT-141 Nasal Spray?
- Sexual health has two sides: the physical response of increased blood flow and the psychological response of libido3.
- PT-141 may support both through its effects on central signaling pathways involved in desire, pleasure, and sexual response1 2
- Unlike blood flow medications for ED, PT-141 may support the upstream signaling pathways that initiate libido and arousal3
- Nasal delivery offers a rapid, needle-free approach for as-needed support of sexual performance and satisfaction1 3
- In one study, response was observed as early as 30 minutes after dosing, faster than other sexual performance medications1
- Compounded by US-licensed pharmacies
PT-141 NASAL SPRAY BENEFITS
Desire changing is more common than we think
- Low libido affects up to 50% of women and 30% of men, becoming more common with age4 5
- Changes in desire can reflect shifts in stress, hormone balance, brain signaling, and overall health6 7
- Sexual wellness is closely connected to brain, cardiovascular, and long-term health7 8
- Supporting these brain signaling pathways may help improve intimacy, satisfaction, and quality of life2 9
- Simple, discreet use designed to fit easily into everyday routines
PT-141 Nasal Spray has not been approved by the FDA for these uses.
The Science of PT-141
Clinically studied and centrally acting: Central neuropeptide signaling declines with age, adversely affecting libido, desire, and overall brain health.10 11 PT-141 binds to melanocortin-4 receptors in the brain, enhancing dopamine release and amplifying sexual motivation, arousal, and pleasure.3
Supports central signaling and vitality: Sexual desire and arousal begin in the brain before they become a physical response.6 PT-141 Nasal Spray directly targets the brain’s control center for desire and arousal, making it broadly effective across sexes.1 2 Emerging research suggests it may support brain signaling pathways that reduce stress, inflammation, and broader markers of health, connecting sexual function with longevity.8 12
Why AgelessRx?
Personalized care guided by US-licensed clinicians
Backed by our Stanford PhD-led Research Team
Treatments are clinically vetted and clinician-reviewed
100% online, ongoing check-ins, and free shipping
Our customers think we’re excellent
-
Dave P.
I’d give 6 stars if possible!! I was skeptical. But no longer. The products are of highest quality and customer service is fast, convenient and thorough. Highly recommend!
-
Christina A.
No hidden fees, no monthly fees. I only pay for the medication itself. I can’t stop raving about AgelessRx because every other company I looked into was the complete opposite.
-
Kevin D.
Customer service is excellent and timely response. The research and development of this company is phenomenal. Very educational.
-
Brooke X.
Reliable source of quality products. Shipping is fast and follow up is quick, allowing for any questions or concerns to be addressed. I feel confident when using Ageless RX as a partner is my health & wellness journey.
-
Karey K.
They really care about making peoples lives more healthy and productive. The medical staff goes above and beyond to ensure your happy with your prescriptions.
-
Shelagh H.
Health providers are friendly and knowledgeable; made it easy to speak with them directly or to remotely ask a question. Highly recommend!
Ready to get started?
Start your free online visit now.
- 100% online medical assessment
- Free shipping and ongoing support
- Unlimited dosing adjustments and provider messaging
- On-demand use, taken as directed prior to sexual activity
- Compounded at US-licensed pharmacy
- Pause or cancel anytime
Code PT141NS50: $149 for first month and FREE medical evaluation ($199/month after)
PT-141 Nasal Spray is not available in AL & AR.
You will be automatically billed & sent refills based on your plan
You can pause or cancel at any time before your next shipment
The FDA has not approved or reviewed PT-141 Nasal Spray for safety, efficacy, quality, or for any use, including the AgelessRx compounded product.
Prescription products require an online evaluation with a licensed medical professional who will determine if a prescription is appropriate. See below for important safety information. Benefits outlined on AgelessRx.com are based on 3rd party studies. Medication is offered as a subscription service which you can cancel at any time. Actual product packaging may appear differently than shown.
FAQs
What is PT-141 Nasal Spray?
PT-141 (Bremelanotide) is a melanocortin receptor agonist peptide that works through the central nervous system to support sexual desire, arousal, and satisfaction.2 PT-141 Nasal Spray provides brain-targeted, rapid-acting support for signaling pathways involved in initiating desire, arousal, and sexual response rather than affecting blood flow alone.1 2 13
How does PT-141 Nasal Spray work?
PT-141 Nasal Spray may activate melanocortin receptors in the brain associated with sexual motivation and arousal signaling.3 This may help enhance sexual interest, responsiveness, and satisfaction in both men and women.1 2
What benefits can I expect from PT-141 Nasal Spray?
Individual results vary, and benefits are not guaranteed. Some users may experience increased sexual desire and libido, improved arousal response, enhanced sexual satisfaction, and improved overall mood and motivation.2 9
See all FAQsImportant safety information and common side effects
Side effects
The most common side effects of PT-141 Nasal Spray include:
- Nausea
- Facial flushing
- Headache
- Fatigue
- Temporary increase in blood pressure
- Mild irritation or sensitivity
These side effects are typically mild and often go away on their own within a week or two.
For a full list of side effects, please review Mayo Clinic’s Bremelanotide resources.
Potential drug interactions
PT-141 Nasal Spray may have the following interactions with certain drugs:
- Naltrexone for alcohol or opioid use disorder
May decrease naltrexone levels and efficacy. - PDE-5 Inhibitors (sildenafil, tadalafil)
May increase the risk of priapism or prolonged erection, a medical emergency. - Potassium Citrate and Potassium Chloride
May increase risk of ulcerative colitis or stenotic lesions. - Antibiotics and Anti-Tuberculosis Agents
May decrease peak antibiotic levels.
Please read the full list of possible drug interactions with PT-141 (Bremelanotide).
Other important safety information
PT-141 Nasal Spray is intended for adults only. Your prescriber may ask you for additional information if you have cardiovascular risk factors or severe liver or kidney disease.
Do not use PT-141 Nasal Spray if you have uncontrolled high blood pressure or if you have significant heart dysfunction (ejection fraction <50% or NYHA Class 3 or greater)
Do not use PT-141 Nasal Spray if you have an active cancer, or if you have had cancer within the last two years.
Do not use PT-141 Nasal Spray if you are pregnant, breastfeeding, or planning to become pregnant or breastfeed. If you become pregnant during treatment, discontinue immediately and consult your OB.
Though rare, allergic reactions to PT-141 Nasal Spray are still possible. If you notice any shortness of breath or swelling around your face, tongue, or throat after using PT-141 Nasal Spray, stop use and contact emergency services right away.
As with any prescription medication, the dose prescribed is for you and you alone. Do not, under any circumstances, allow anyone else to use your PT-141 Nasal Spray.
Show me the science.
All our claims are backed by science, and we’ve got the receipts.
| 1. A review highlighting several clinical trials in which intranasal PT-141 improves erectile function and sexual satisfaction in men with erectile dysfunction, including individuals that don’t respond to Viagra. | World J Mens Health, 2021 |
| 2. A clinical study highlighting that intranasal PT-141 improved arousal, sexual desire, and satisfaction in premenopausal women with female sexual arousal disorder. | Journ of Sex Med, 2006 |
| 3. A review highlighting evidence that intranasal PT-141 enhances sexual function through melanocortin receptor signaling, improving both quality and duration. | Curr Top Med Chem, 2009 |
| 4. A large observation study highlighting the incidence of low libido in women, especially post menopause. | JAMA Intern Med, 2008 |
| 5. An observational study highlighting that nearly 30% of men with ED have low sexual desire, which is associated with lower testosterone, more severe ED, and higher depressive symptoms. | Nature, 2022 |
| 6. A review outlining how neurotransmitters and hormones such as dopamine, serotonin, oxytocin, and cortisol interact to influence desire, arousal, orgasm, and overall sexual well-being, particularly under conditions of stress. | Journ Psy Health, 2026 |
| 7. An observation study highlighting how declines in sexual desire, activity, and erectile function in older adults is associated with higher risks of chronic illness, cardiovascular disease, and cancer. | Arch Sex Behav, 2019 |
| 8. A large study demonstrating that higher frequency of sexual activity is associated with reduced risk of all-cause and cancer mortality in middle-aged adults, suggesting sexual activity as an indicator of overall health. | The Journal of Sexual Medicine, 2020 |
| 9. A clinical trial highlighting that intranasal PT-141 improved erectile function, intimacy, and quality of life in men with diabetic ED. | The Journal of Urology, 2007 |
| 10. A review highlighting that sexual behavior is regulated by complex interactions between neurotransmitter systems, particularly dopamine and serotonin, and emphasizing its critical role in overall health and quality of life. | Brain Behav, 2019 |
| 11. A study demonstrating that age-related declines in dopamine signaling are associated with reduced cognitive performance, suggesting that enhancing dopamine function may support brain health. | Amer Journ Sci, 1998 |
| 12. A review highlighting melanocortin signaling as a key regulatos of immune function with demonstrated anti-inflammatory and immunomodulatory effects. | Front. Endocrinol, 2019 |
| 13. A clinical study highlighting that intranasal PT-141 improves erectile function and intercourse satisfaction in Viagra nonresponders. | Journ of Urology, 2008 |
